{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:15:32Z","timestamp":1793391332833,"version":"4.5.0"},"reference-count":361,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["DEC-2011\/01\/D\/NZ3\/00262"],"award-info":[{"award-number":["DEC-2011\/01\/D\/NZ3\/00262"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001870","name":"Fundacja na rzecz Nauki Polskiej","doi-asserted-by":"publisher","award":["MAB\/2017\/3"],"award-info":[{"award-number":["MAB\/2017\/3"]}],"id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010609","name":"Gda\u0144ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["ST-49"],"award-info":[{"award-number":["ST-49"]}],"id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["POWR.03.05.00-00-z082\/18"],"award-info":[{"award-number":["POWR.03.05.00-00-z082\/18"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune disease results from the immune response against self-antigens, while cancer develops when the immune system does not respond to malignant cells. Thus, for years, autoimmunity and cancer have been considered as two separate fields of research that do not have a lot in common. However, the discovery of immune checkpoints and the development of anti-cancer drugs targeting PD-1 (programmed cell death receptor 1) and CTLA-4 (cytotoxic T lymphocyte antigen 4) pathways proved that studying autoimmune diseases can be extremely helpful in the development of novel anti-cancer drugs. Therefore, autoimmunity and cancer seem to be just two sides of the same coin. In the current review, we broadly discuss how various regulatory cell populations, effector molecules, genetic predisposition, and environmental factors contribute to the loss of self-tolerance in autoimmunity or tolerance induction to cancer. With the current paper, we also aim to convince the readers that the pathways involved in cancer and autoimmune disease development consist of similar molecular players working in opposite directions. Therefore, a deep understanding of the two sides of immune tolerance is crucial for the proper designing of novel and selective immunotherapies.<\/jats:p>","DOI":"10.3389\/fimmu.2022.793234","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T08:32:45Z","timestamp":1652430765000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":72,"title":["Autoimmunity and Cancer\u2014Two Sides of the Same Coin"],"prefix":"10.3389","volume":"13","author":[{"given":"Justyna","family":"Sakowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Arcimowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Jankowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Papak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Markiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Dziubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Kurkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Ka\u017amierczak-Siedlecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Po\u0142om","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Marek-Trzonkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Trzonkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00454-2","article-title":"Rethinking Peripheral T Cell Tolerance: Checkpoints Across a T Cell\u2019s Journey","volume":"21","author":"ElTanbouly","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12885-018-4441-3","article-title":"Mechanisms of Immune Evasion in Breast Cancer","volume":"18","author":"Bates","year":"2018","journal-title":"BMC Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1764309","article-title":"Therapeutic Methods of Gut Microbiota Modification in Colorectal Cancer Management \u2013 Fecal Microbiota Transplantation, Prebiotics, Probiotics, and Synbiotics","volume":"11","author":"Ka\u017amierczak-Siedlecka","year":"2020","journal-title":"Gut Microbes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium Nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment","volume":"14","author":"Kostic","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-021-01260-y","article-title":"Interdisciplinary Insights Into the Link Between Gut Microbiome and Gastric Carcinogenesis\u2014What is Currently Known","volume":"25","author":"Ka\u017amierczak-Siedlecka","year":"2022","journal-title":"Gastric Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12866-021-02315-x","article-title":"Interplay and Cooperation of Helicobacter Pylori and Gut Microbiota in Gastric Carcinogenesis","volume":"21","author":"Bakhti","year":"2021","journal-title":"BMC Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2018.06.012","article-title":"Role of Non-Albicans Candida and Candida Albicans in Oral Squamous Cell Cancer Patients","volume":"76","author":"M\u00e4kinen","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.11.041","article-title":"Cancer and the Microbiome\u2014Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy","volume":"160","author":"Matson","year":"2021","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.01.015","article-title":"Gut Microbiome and Cancer Immunotherapy","volume":"447","author":"Li","year":"2019","journal-title":"Cancer Lett"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706","article-title":"Gut Microbiome Influences Efficacy of PD-1\u2013Based Immunotherapy Against Epithelial Tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science (80- )"},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/TACG.S33966","article-title":"Genetic Variants Associated With Crohn\u2019s Disease","volume":"6","author":"Michail","year":"2013","journal-title":"Appl Clin Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1949096","article-title":"Dysbiotic Microbiota Interactions in Crohn\u2019s Disease","volume":"13","author":"Caparr\u00f3s","year":"2021","journal-title":"Gut Microbes"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.025403","article-title":"Reduction in Diversity of the Colonic Mucosa Associated Bacterial Microflora in Patients With Active Inflammatory Bowel Disease","volume":"53","author":"Ott","year":"2004","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-013-0290-5","article-title":"TLR4, IL10RA, and NOD2 Mutation in Paediatric Crohn\u2019s Disease Patients: An Association With Mycobacterium Avium Subspecies Paratuberculosis and TLR4 and IL10RA Expression","volume":"202","author":"Wagner","year":"2013","journal-title":"Med Microbiol Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 Leucine-Rich Repeat Variants With Susceptibility to Crohn\u2019s Disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4103\/sjg.sjg_613_20","article-title":"NOD2\/CARD15 Polymorphisms (P268S, IVS8 +158 , G908R, L1007fs, R702W) Among Kuwaiti Patients With Crohn\u2019s Disease: A Case-Control Study","volume":"27","author":"Abdelnaby","year":"2021","journal-title":"Saudi J Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular Mimicry as a Mechanism of Autoimmune Disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115573","article-title":"Autoimmunity to Two Forms of Glutamate Decarboxylase in Insulin-Dependent Diabetes Mellitus","volume":"89","author":"Kaufman","year":"1992","journal-title":"J Clin Invest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12011","article-title":"Viral Infections and Molecular Mimicry in Type 1 Diabetes","volume":"120","author":"Coppieters","year":"2012","journal-title":"APMIS"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2789242","article-title":"Genetic Factors of Autoimmune Diseases 2017","volume":"2017","author":"Ceccarelli","year":"2017","journal-title":"J Immunol Res"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-39926-3_1","article-title":"\u201cHLA and Autoimmunity\u201d","volume-title":"Immunogenetics of Autoimmune Disease","author":"Wucherpfennig","year":"2006"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-011-0223-x","article-title":"Genetics of the HLA Region in the Prediction of Type 1 Diabetes","volume":"11","author":"Noble","year":"2011","journal-title":"Curr Diabetes Rep"},{"key":"B24","first-page":"5","article-title":"HLA Class II Polymorphism: Implications for Genetic Susceptibility to Autoimmune Disease","volume":"61","author":"Gregersen","year":"1989","journal-title":"Lab Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.633219","article-title":"Variant to Gene Mapping to Discover New Targets for Immune Tolerance","volume":"12","author":"Mehra","year":"2021","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00622","article-title":"B Cell Modulation Strategies in Autoimmune Diseases: New Concepts","volume":"9","author":"Musette","year":"2018","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.07.005","article-title":"The Cellular Mechanism of Aire Control of T Cell Tolerance","volume":"23","author":"Anderson","year":"2005","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040581","article-title":"Gene Dosage\u2013limiting Role of Aire in Thymic Expression, Clonal Deletion, and Organ-Specific Autoimmunity","volume":"200","author":"Liston","year":"2004","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/11.4.397","article-title":"Aire Deficient Mice Develop Multiple Features of APECED Phenotype and Show Altered Immune Response","volume":"11","author":"Ramsey","year":"2002","journal-title":"Hum Mol Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ng1297-393","article-title":"Positional Cloning of the APECED Gene","volume":"17","author":"Nagamine","year":"1997","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2005.09.022","article-title":"Autoimmune Polyendocrinopathy Syndrome Type 1 (APS1) and AIRE Gene: New Views on Molecular Basis of Autoimmunity","volume":"25","author":"Peterson","year":"2005","journal-title":"J Autoimmun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11350","article-title":"Sex Bias in CNS Autoimmune Disease Mediated by Androgen Control of Autoimmune Regulator","volume":"7","author":"Zhu","year":"2016","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81894","article-title":"Estrogen-Mediated Downregulation of AIRE Influences Sexual Dimorphism in Autoimmune Diseases","volume":"126","author":"Dragin","year":"2016","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V104.11.2657.2657","article-title":"CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms","volume":"104","author":"Chemnitz","year":"2004","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e001439","DOI":"10.1136\/jitc-2020-001439","article-title":"Autoimmunity Linked Protein Phosphatase PTPN22 as a Target for Cancer Immunotherapy","volume":"8","author":"Cubas","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0713370","article-title":"Cutting Edge: The PTPN22 Allelic Variant Associated With Autoimmunity Impairs B Cell Signaling","volume":"182","author":"Arechiga","year":"2009","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/ng1205-1300","article-title":"Gaining Insight Into PTPN22 and Autoimmunity","volume":"37","author":"Gregersen","year":"2005","journal-title":"Nat Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1086\/422827","article-title":"A Missense Single-Nucleotide Polymorphism in a Gene Encoding a Protein Tyrosine Phosphatase (PTPN22) is Associated With Rheumatoid Arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am J Hum Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1108","article-title":"The Codon 620 Tryptophan Allele of the Lymphoid Tyrosine Phosphatase (LYP) Gene is a Major Determinant of Graves\u2019 Disease","volume":"89","author":"Velaga","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.11.3020","article-title":"Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP\/PTPN22) With Type 1 Diabetes, and Evidence for its Role as a General Autoimmunity Locus","volume":"53","author":"Smyth","year":"2004","journal-title":"Diabetes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ng1323","article-title":"A Functional Variant of Lymphoid Tyrosine Phosphatase is Associated With Type I Diabetes","volume":"36","author":"Bottini","year":"2004","journal-title":"Nat Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146950","article-title":"Systemic Inhibition of PTPN22 Augments Anticancer Immunity","volume":"131","author":"Ho","year":"2021","journal-title":"J Clin Invest"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8648-x","article-title":"Sexual Dimorphism in Innate Immunity","volume":"56","author":"Jaillon","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S1995-7645(13)60131-5","article-title":"Effects of Estrogen on CD4+ CD25+ Regulatory T Cell in Peripheral Blood During Pregnancy","volume":"6","author":"Xiong","year":"2013","journal-title":"Asian Pac J Trop Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2011.02931.x","article-title":"What can We Really Tell Women With Multiple Sclerosis Regarding Pregnancy? A Systematic Review and Meta-Analysis of the Literature","volume":"118","author":"Finkelsztejn","year":"2011","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen Receptors Regulate Innate Immune Cells and Signaling Pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cell Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101280","article-title":"The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View","volume":"8","author":"Maglione","year":"2019","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21221","article-title":"Induction of Regulatory T Cells by Physiological Level Estrogen","volume":"214","author":"Tai","year":"2008","journal-title":"J Cell Physiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00240110","article-title":"A Systematic Review and Meta-Analysis of Pregnancy Outcomes in Patients With Systemic Lupus Erythematosus and Lupus Nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00172","article-title":"Differential Roles of Estrogen Receptors \u03b1 and \u03b2 in Control of B-Cell Maturation and Selection","volume":"17","author":"Hill","year":"2011","journal-title":"Mol Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1200","article-title":"Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer","volume":"81","author":"Williams","year":"2021","journal-title":"Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/jbmr.3364","article-title":"Estrogen Deficiency\u2013Mediated M2 Macrophage Osteoclastogenesis Contributes to M1\/M2 Ratio Alteration in Ovariectomized Osteoporotic Mice","volume":"33","author":"Dou","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.175","article-title":"Estrogen Receptor-Alpha Promotes Alternative Macrophage Activation During Cutaneous Repair","volume":"134","author":"Campbell","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01909","article-title":"Not All Immune Checkpoints Are Created Equal","volume":"9","author":"De Sousa Linhares","year":"2018","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 Leads to Massive Lymphoproliferation and Fatal Multiorgan Tissue Destruction, Revealing a Critical Negative Regulatory Role of CTLA-4","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative Disorders With Early Lethality in Mice Deficient in Ctla-4","volume":"270","author":"Waterhouse","year":"1995","journal-title":"Science (80- )"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science (80- )"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of Lupus-Like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxr017","article-title":"Lack of B and T Lymphocyte Attenuator Exacerbates Autoimmune Disorders and Induces Fas-Independent Liver Injury in MRL-Lpr\/Lpr Mice","volume":"23","author":"Oya","year":"2011","journal-title":"Int Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1407447111","article-title":"Disruption of the Immune-Checkpoint VISTA Gene Imparts a Proinflammatory Phenotype With Predisposition to the Development of Autoimmunity","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003081","article-title":"Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions","volume":"186","author":"Joller","year":"2011","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/08820139.2012.724752","article-title":"CTLA-4 -1722t\/C Polymorphism and Systemic Lupus Erythematosus Susceptibility: A Meta-Analysis Involving Ten Separate Studies","volume":"42","author":"Zhu","year":"2013","journal-title":"Immunol Invest"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107617","article-title":"Association of CTLA-4 (+49 A\/G) Polymorphism With Susceptibility to Autoimmune Diseases: A Meta-Analysis With Trial Sequential Analysis","volume":"96","author":"Yu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00296-015-3327-9","article-title":"The Associations Between PD-1, CTLA-4 Gene Polymorphisms and Susceptibility to Ankylosing Spondylitis: A Meta-Analysis and Systemic Review","volume":"36","author":"Chen","year":"2016","journal-title":"Rheumatol Int"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181235","article-title":"TIM-3 Rs1036199 Polymorphism Increases Susceptibility to Autoimmune Diseases: Evidence Based on 4200 Subjects","volume":"38","author":"Liu","year":"2018","journal-title":"Biosci Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16378","article-title":"Meta-Analysis of Programmed Cell Death 1 Polymorphisms With Systemic Lupus Erythematosus Risk","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-014-1415-y","article-title":"Meta-Analysis of Genetic Polymorphisms in Programmed Cell Death 1","volume":"74","author":"Lee","year":"2015","journal-title":"Z Rheumatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312458840","article-title":"Association Between the CD226 Rs763361 Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-Analysis","volume":"21","author":"Song","year":"2012","journal-title":"Lupus"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2017.02.006","article-title":"PD-1 Gene Polymorphic Variation is Linked With First Symptom of Disease and Severity of Relapsing-Remitting Form of MS","volume":"305","author":"Pawlak-Adamska","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20514","article-title":"A PD-1 Polymorphism is Associated With Disease Progression in Multiple Sclerosis","volume":"58","author":"Kroner","year":"2005","journal-title":"Ann Neurol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-065X.2009.00770.x","article-title":"CD28 and CTLA-4 Coreceptor Expression and Signal Transduction","volume":"229","author":"Rudd","year":"2009","journal-title":"Immunol Rev"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200695","article-title":"Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans","volume":"189","author":"Corse","year":"2012","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202947","article-title":"Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science (80- )"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0910341107","article-title":"Dual Function of CTLA-4 in Regulatory T Cells and Conventional T Cells to Prevent Multiorgan Autoimmunity","volume":"107","author":"Jain","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12997","article-title":"Immune Deficiency and Autoimmunity in Patients With CTLA-4 (CD152) Mutations","volume":"190","author":"Verma","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1159\/000490025","article-title":"Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy","volume":"47","author":"Zhao","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27455","article-title":"The Functional Cytotoxic T Lymphocyte-Associated Protein 4 49G-to-A Genetic Variant and Risk of Pancreatic Cancer","volume":"118","author":"Yang","year":"2012","journal-title":"Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1844-3","article-title":"CTLA-4 in Mesothelioma Patients: Tissue Expression, Body Fluid Levels and Possible Relevance as a Prognostic Factor","volume":"65","author":"Roncella","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13063-022-06036-y","article-title":"Combining Hepatic Percutaneous Perfusion With Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma (CHOPIN): Study Protocol for a Phase Ib\/Randomized Phase II Trial","volume":"23","author":"Tong","year":"2022","journal-title":"Trials"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0762","article-title":"Anti-CTLA-4 Immunotherapy Does Not Deplete Foxp3 \u00de Regulatory T Cells (Tregs) in Human Cancers","volume":"25","author":"Sharma","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1417320112","article-title":"Ipilimumab-Dependent Cell-Mediated Cytotoxicity of Regulatory T Cells Ex Vivo by Nonclassical Monocytes in Melanoma Patients","volume":"112","author":"Romano","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 Pathway in Tolerance and Autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051776","article-title":"Tissue Expression of PD-L1 Mediates Peripheral T Cell Tolerance","volume":"203","author":"Keir","year":"2006","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is Expressed in the Islets of People With Type 1 Diabetes and is Up-Regulated by Interferons-\u03b1 and-\u03b3 via IRF1 Induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"8295","DOI":"10.1038\/s41598-018-26471-9","article-title":"Interferon-Gamma Drives Programmed Death-Ligand 1 Expression on Islet \u03b2 Cells to Limit T Cell Function During Autoimmune Diabetes","volume":"8","author":"Osum","year":"2018","journal-title":"Sci Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 Regulates the Development, Maintenance, and Function of Induced Regulatory T Cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken256","article-title":"Active Systemic Lupus Erythematosus is Associated With Failure of Antigen-Presenting Cells to Express Programmed Death Ligand-1","volume":"47","author":"Mozaffarian","year":"2008","journal-title":"Rheumatology"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1475","article-title":"PD-1, But Not PD-L1, Expressed by Islet-Reactive CD4+ T Cells Suppresses Infiltration of the Pancreas During Type 1 Diabetes","volume":"62","author":"Pauken","year":"2013","journal-title":"Diabetes"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0610332","article-title":"PD-L1 Hi Retinal Pigment Epithelium (RPE) Cells Elicited by Inflammatory Cytokines Induce Regulatory Activity in Uveitogenic T Cells","volume":"88","author":"Ke","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02699-1","article-title":"Autoimmune Polyendocrine Syndrome Induced by Immune Checkpoint Inhibitors: A Systematic Review","volume":"70","author":"Zhao","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1159\/000477162","article-title":"PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis","volume":"10","author":"Schneider","year":"2017","journal-title":"Case Rep Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","article-title":"PD-1 Alters T-Cell Metabolic Reprogramming by Inhibiting Glycolysis and Promoting Lipolysis and Fatty Acid Oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-206672","article-title":"PD-1\/PD-L1 Interactions Inhibit Antitumor Immune Responses in a Murine Acute Myeloid Leukemia Model","volume":"114","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 Contributes to Immunosuppression and is Associated With Anti-PD-1 Response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS13164148","article-title":"PD-L1 Overexpression, SWI\/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4+ T Cells","volume":"13","author":"Jancewicz","year":"2021","journal-title":"Cancers"},{"key":"B96","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/bfgp\/ely006","article-title":"CD8+ T-Cell Exhaustion in Cancer: Mechanisms and New Area for Cancer Immunotherapy","volume":"18","author":"He","year":"2019","journal-title":"Brief Funct Genomics"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on Tumor Cells in the Escape From Host Immune System and Tumor Immunotherapy by PD-L1 Blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00403","article-title":"Dual Role of Fas\/FasL-Mediated Signal in Peripheral Immune Tolerance","volume":"8","author":"Yamada","year":"2017","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/ni1328","article-title":"See No Evil, Hear No Evil, Do No Evil: The Lessons of Immune Privilege","volume":"7","author":"Niederkorn","year":"2006","journal-title":"Nat Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.159.1.1","article-title":"A New Mutation, Gld, That Produces Lymphoproliferation and Autoimmunity in C3H\/HeJ Mice","volume":"159","author":"Roths","year":"1984","journal-title":"J Exp Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(94)90013-2","article-title":"Apoptosis, Fas and Systemic Autoimmunity: The MRL-Ipr\/Ipr Model","volume":"6","author":"Singer","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564286","article-title":"Abnormally Differentiated CD4+ or CD8+ T Cells With Phenotypic and Genetic Features of Double Negative T Cells in Human Fas Deficiency","volume":"124","author":"Rensing-Ehl","year":"2014","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00402","article-title":"Expansion of FasL-Expressing CD5+ B Cells in Type 1 Diabetes Patients","volume":"8","author":"Saxena","year":"2017","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/thy.2006.0231","article-title":"Apoptosis-Induced Decrease of Intrathyroidal CD4 + CD25 + Regulatory T Cells in Autoimmune Thyroid Diseases","volume":"17","author":"Nakano","year":"2007","journal-title":"Thyroid"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12895","article-title":"Defective Expression of Apoptosis-Related Molecules in Multiple Sclerosis Patients is Normalized Early After Autologous Haematopoietic Stem Cell Transplantation","volume":"187","author":"de Oliveira","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.7.928","article-title":"Apoptosis Mediators FasL and TRAIL are Upregulated in Peripheral Blood Mononuclear Cells in MS","volume":"55","author":"Huang","year":"2000","journal-title":"Neurology"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/science.7510905","article-title":"Protection From Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule","volume":"263","author":"Cheng","year":"1994","journal-title":"Science (80- )"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.7.1209","article-title":"Opposing Effects of Transmembrane and Soluble FAS Ligand Expression on Inflammation and Tumor Cell Survival","volume":"191","author":"Hohlbaum","year":"2000","journal-title":"J Exp Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e000375","DOI":"10.1136\/lupus-2019-000375","article-title":"Associations of Serum Soluble Fas and Fas Ligand (FasL) With Outcomes in Systemic Lupus Erythematosus","volume":"7","author":"Vincent","year":"2020","journal-title":"Lupus Sci Med"},{"key":"B110","article-title":"Serum Soluble Fas and Fas Ligand (FasL) in Primary Sj\u00f6gren\u2019s Syndrome","author":"Vincent","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1158\/2326-6066.CIR-17-0249","article-title":"Intratumoral CD8 + T-Cell Apoptosis Is a Major Component of T-Cell Dysfunction and Impedes Antitumor Immunity","volume":"6","author":"Horton","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7701008","article-title":"The Effects of FasL on Inflammation and Tumor Survival are Dependent on its Expression Levels","volume":"14","author":"Wada","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/s41467-017-00784-1","article-title":"Resistance to Cancer Immunotherapy Mediated by Apoptosis of Tumor-Infiltrating Lymphocytes","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat Commun"},{"key":"B114","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","article-title":"Galectin-9 Suppresses the Generation of Th17, Promotes the Induction of Regulatory T Cells, and Regulates Experimental Autoimmune Arthritis","volume":"127","author":"Seki","year":"2008","journal-title":"Clin Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/ni1271","article-title":"The Tim-3 Ligand Galectin-9 Negatively Regulates T Helper Type 1 Immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803161","article-title":"Cutting Edge: A Critical Role of B and T Lymphocyte Attenuator in Peripheral T Cell Tolerance Induction","volume":"182","author":"Liu","year":"2009","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/srep29699","article-title":"B Lymphocytes in Multiple Sclerosis: Bregs and BTLA\/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity","volume":"6","author":"Piancone","year":"2016","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667991","article-title":"BTLA Expression and Function Are Impaired on SLE B Cells","volume":"12","author":"Wiedemann","year":"2021","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184505","article-title":"BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients With Systemic Lupus Erythematosus Is Associated With Active Disease","volume":"20","author":"Oster","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13148","article-title":"Tim-3 Suppresses Autoimmune Hepatitis via the P38\/MKP-1 Pathway in Th17 Cells","volume":"11","author":"Wu","year":"2021","journal-title":"FEBS Open Bio"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402381","article-title":"Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226","volume":"195","author":"Fuhrman","year":"2015","journal-title":"J Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-019-09112-9","article-title":"CD226 Attenuates Treg Suppressive Capacity via CTLA-4 and TIGIT During EAE","volume":"67","author":"Wang","year":"2019","journal-title":"Immunol Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e000266","DOI":"10.1136\/jitc-2019-000266","article-title":"Nectin4 is a Novel TIGIT Ligand Which Combines Checkpoint Inhibition and Tumor Specificity","volume":"8","author":"Reches","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B124","first-page":"69","volume-title":"\u201cCentral Tolerance Induction\u201d","author":"Mouchess","year":"2013"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00395","article-title":"Regulatory T-Cell Development in the Human Thymus","volume":"6","author":"Caramalho","year":"2015","journal-title":"Front Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1952","article-title":"IL-35-Mediated Induction of a Potent Regulatory T Cell Population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.44","article-title":"Type 1 Regulatory T Cells: A New Mechanism of Peripheral Immune Tolerance","volume":"12","author":"Zeng","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2001.1820117.x","article-title":"Induction and Mechanism of Action of Transforming Growth Factor-\u03b2-Secreting Th3 Regulatory Cells","volume":"182","author":"Weiner","year":"2001","journal-title":"Immunol Rev"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1620602","article-title":"Regulatory T Cells: The Future of Autoimmune Disease Treatment","volume":"15","author":"Ryba-Stanis\u0142awowska","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15067","article-title":"T Follicular Helper and T Follicular Regulatory Cells Have Different TCR Specificity","volume":"8","author":"Maceiras","year":"2017","journal-title":"Nat Commun"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130604","article-title":"Follicular Regulatory T Cells Control Humoral Autoimmunity via NFAT2-Regulated CXCR5 Expression","volume":"211","author":"Vaeth","year":"2014","journal-title":"J Exp Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030686","article-title":"Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State","volume":"198","author":"Fisson","year":"2003","journal-title":"J Exp Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.05.029","article-title":"Neutrophil \u2013 CD4+CD25+ T Regulatory Cell Interactions: A Possible New Mechanism of Infectious Tolerance","volume":"218","author":"Lewkowicz","year":"2013","journal-title":"Immunobiology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-28338-0","article-title":"Mesenchymal Stem Cells Transfer Mitochondria to Allogeneic Tregs in an HLA-Dependent Manner Improving Their Immunosuppressive Activity","volume":"13","author":"Piekarska","year":"2022","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of Immune Responses by Extracellular Vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.celrep.2019.12.081","article-title":"Treg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance","volume":"30","author":"Sullivan","year":"2020","journal-title":"Cell Rep"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.612760","article-title":"IPEX Syndrome: Improved Knowledge of Immune Pathogenesis Empowers Diagnosis","volume":"9","author":"Barzaghi","year":"2021","journal-title":"Front Pediatr"},{"key":"B138","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","article-title":"X-Linked Neonatal Diabetes Mellitus, Enteropathy and Endocrinopathy Syndrome is the Human Equivalent of Mouse Scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.10.6435","article-title":"CD4 + CD25 Bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients With the Remitting Form of Juvenile Idiopathic Arthritis","volume":"172","author":"de Kleer","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/art.20499","article-title":"CD4+CD25+ Regulatory T Cells in Rheumatoid Arthritis: Differences in the Presence, Phenotype, and Function Between Peripheral Blood and Synovial Fluid","volume":"50","author":"van Amelsfort","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B141","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","article-title":"Regulatory T Cells (CD4+CD25brightFoxP3+) Expansion in Systemic Sclerosis Correlates With Disease Activity and Severity","volume":"261","author":"Slobodin","year":"2010","journal-title":"Cell Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0714-8","article-title":"Tregs in SLE: An Update","volume":"20","author":"La Cava","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and Qualitative Deficiencies of Regulatory T Cells in Patients With Systemic Lupus Erythematosus (SLE)","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4+CD25+ Regulatory T-Cells in Autoimmune Liver Disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00498","article-title":"Patients With Autoimmune Thyroiditis Show Diminished Levels and Defective Suppressive Function of Tr1 Regulatory Lymphocytes","volume":"103","author":"Vitales-Noyola","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2337","article-title":"Regulatory T Cells in Human Autoimmune Thyroid Disease","volume":"91","author":"Marazuela","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.08.003","article-title":"CD4+CD25+FoxP3+ T Lymphocytes Fail to Suppress Myelin Basic Protein-Induced Proliferation in Patients With Multiple Sclerosis","volume":"180","author":"Kumar","year":"2006","journal-title":"J Neuroimmunol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4 + CD25 High Regulatory T-Cell Function in Patients With Relapsing-Remitting Multiple Sclerosis is Correlated With a Reduced Frequency of FOXP3-Positive Cells and Reduced FOXP3 Expression at the Single-Cell Level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e0217728","DOI":"10.1371\/journal.pone.0217728","article-title":"Thymically-Derived Foxp3+ Regulatory T Cells are the Primary Regulators of Type 1 Diabetes in the non-Obese Diabetic Mouse Model","volume":"14","author":"Holohan","year":"2019","journal-title":"PloS One"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500391","article-title":"Synovial Regulatory T Cells Occupy a Discrete TCR Niche in Human Arthritis and Require Local Signals To Stabilize FOXP3 Protein Expression","volume":"195","author":"Bending","year":"2015","journal-title":"J Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb0606","article-title":"Induced, But Not Natural, Regulatory T Cells Retain Phenotype and Function Following Exposure to Inflamed Synovial Fibroblasts","volume":"6","author":"Yang","year":"2020","journal-title":"Sci Adv"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00733-8","article-title":"The Pathogenicity of Th17 Cells in Autoimmune Diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-443473","article-title":"CD161 Defines the Subset of FoxP3+ T Cells Capable of Producing Proinflammatory Cytokines","volume":"121","author":"Pesenacker","year":"2013","journal-title":"Blood"},{"key":"B154","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-018-8721-0","article-title":"Regulatory T Cell Plasticity and Stability and Autoimmune Diseases","volume":"58","author":"Qiu","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep15179","article-title":"Prognostic Value of Tumor-Infiltrating FoxP3+ Regulatory T Cells in Cancers: A Systematic Review and Meta-Analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci Rep"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0341","article-title":"CCR5-Dependent Homing of T Regulatory Cells to the Tumor Microenvironment Contributes to Skin Squamous Cell Carcinoma Development","volume":"16","author":"De Oliveira","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23392","article-title":"CCL17 and CCL22 Chemokines Within Tumor Microenvironment are Related to Accumulation of Foxp3+ Regulatory T Cells in Gastric Cancer","volume":"122","author":"Mizukami","year":"2008","journal-title":"Int J Cancer"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024590","article-title":"All-Trans Retinoic Acid Promotes TGF-\u03b2-Induced Tregs via Histone Modification But Not DNA Demethylation on Foxp3 Gene Locus","volume":"6","author":"Lu","year":"2011","journal-title":"PloS One"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13625","article-title":"Regulatory T Cells: A Potential Target in Cancer Immunotherapy","volume":"1417","author":"Shitara","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines4030028","article-title":"Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting","volume":"4","author":"Chaudhary","year":"2016","journal-title":"Vaccines"},{"key":"B162","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of Tolerance by IL-10-Treated Dendritic Cells","volume":"159","author":"Steinbrink","year":"1997","journal-title":"J Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02689","article-title":"Impairment of NKG2D-Mediated Tumor Immunity by TGF-\u03b2","volume":"10","author":"Lazarova","year":"2019","journal-title":"Front Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2010.03308.x","article-title":"T Regulatory Cells Control T-Cell Proliferation Partly by the Release of Soluble CD25 in Patients With B-Cell Malignancies","volume":"131","author":"Lindqvist","year":"2010","journal-title":"Immunology"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive Plasticity of IL-10+ and IL-35+ Treg Cells Cooperatively Promotes Tumor T Cell Exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat Immunol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 Limits Anti-Tumor Immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-135319","article-title":"Depletion of Human Regulatory T Cells Specifically Enhances Antigen-Specific Immune Responses to Cancer Vaccines","volume":"112","author":"Morse","year":"2008","journal-title":"Blood"},{"key":"B168","first-page":"1","volume-title":"\u201cB Cell Development and Maturation\u201d","author":"Wang","year":"2020"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.19","article-title":"Mechanisms of Central Tolerance for B Cells","volume":"17","author":"Nemazee","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22976","article-title":"Regulatory B Cells Induced by Pancreatic Cancer Cell-Derived Interleukin-18 Promote Immune Tolerance via the PD-1\/PD-L1 Pathway","volume":"9","author":"Zhao","year":"2018","journal-title":"Oncotarget"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46274","article-title":"Regulatory B Cells are Identified by Expression of TIM-1 and can be Induced Through TIM-1 Ligation to Promote Tolerance in Mice","volume":"121","author":"Ding","year":"2011","journal-title":"J Clin Invest"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxz068","article-title":"Heterogeneous Subsets of B-Lineage Regulatory Cells (Breg Cells)","volume":"32","author":"Baba","year":"2020","journal-title":"Int Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00110","article-title":"IL-10-Producing CD1dhiCD5+ Regulatory B Cells May Play a Critical Role in Modulating Immune Homeostasis in Silicosis Patients","volume":"8","author":"Chen","year":"2017","journal-title":"Front Immunol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2010.05.013","article-title":"Characterisation of Allergen-Specific Responses of IL-10-Producing Regulatory B Cells (Br1) in Cow Milk Allergy","volume":"264","author":"Noh","year":"2010","journal-title":"Cell Immunol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a Rare IL-10\u2013Competent B-Cell Subset in Humans That Parallels Mouse Regulatory B10 Cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals But Are Functionally Impaired in Systemic Lupus Erythematosus Patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5588","article-title":"CD19+CD24hiCD38hiBregs Involved in Downregulate Helper T Cells and Upregulate Regulatory T Cells in Gastric Cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"B178","doi-asserted-by":"publisher","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 Production is Confined to Human IL-10-Producing Regulatory B Cells That Suppress Antigen-Specific Immune Responses","volume":"131","author":"Van De Veen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2004.10.001","article-title":"IL-10 Production in B Cells is Confined to CD154 + Cells in Patients With Systemic Lupus Erythematosus","volume":"23","author":"D\u00edaz-Alderete","year":"2004","journal-title":"J Autoimmun"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1408","article-title":"PD-1hi Identifies a Novel Regulatory B-Cell Population in Human Hepatoma That Promotes Disease Progression","volume":"6","author":"Xiao","year":"2016","journal-title":"Cancer Discov"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19+CD25high B Regulatory Cells Suppress Proliferation of CD4+ T Cells and Enhance Foxp3 and CTLA-4 Expression in T-Regulatory Cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B184","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2018.11.008","article-title":"Regulatory and Effector B Cells: Friends or Foes","volume":"93","author":"Matsushita","year":"2019","journal-title":"J Dermatol Sci"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/nature11501","article-title":"Regulatory B Cells Control T-Cell Autoimmunity Through IL-21-Dependent Cognate Interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature"},{"key":"B186","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of Arthritis by Interleukin 10\u2013Producing B Cells","volume":"197","author":"Mauri","year":"2003","journal-title":"J Exp Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902385","article-title":"Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity","volume":"184","author":"Watanabe","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36030","article-title":"Regulatory B Cells Inhibit EAE Initiation in Mice While Other B Cells Promote Disease Progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"B189","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2217\/imt.11.34","article-title":"Regulatory B Cells Control Dendritic Cell Functions","volume":"3","author":"Lo-Man","year":"2011","journal-title":"Immunotherapy"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2016.10.010","article-title":"B Lymphocytes and Cancer: A Love\u2013Hate Relationship","volume":"2","author":"Yuen","year":"2016","journal-title":"Trends Cancer"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-014-0304-0","article-title":"Enhanced Frequency and Potential Mechanism of B Regulatory Cells in Patients With Lung Cancer","volume":"12","author":"Zhou","year":"2014","journal-title":"J Transl Med"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-49581-4","article-title":"Increased Regulatory B Cells are Involved in Immune Evasion in Patients With Gastric Cancer","volume":"9","author":"Murakami","year":"2019","journal-title":"Sci Rep"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-018-0910-4","article-title":"Coexistence of Regulatory B Cells and Regulatory T Cells in Tumor-Infiltrating Lymphocyte Aggregates is a Prognostic Factor in Patients With Breast Cancer","volume":"26","author":"Ishigami","year":"2019","journal-title":"Breast Cancer"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.89014","article-title":"Multiparametric Profiling of Non\u2013Small-Cell Lung Cancers Reveals Distinct Immunophenotypes","volume":"1","author":"Lizotte","year":"2016","journal-title":"JCI Insight"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxw007","article-title":"Mammary-Tumor-Educated B Cells Acquire LAP\/TGF-\u03b2 and PD-L1 Expression and Suppress Anti-Tumor Immune Responses","volume":"28","author":"Zhang","year":"2016","journal-title":"Int Immunol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3450","article-title":"Interleukin 21\u2013Induced Granzyme B\u2013Expressing B Cells Infiltrate Tumors and Regulate T Cells","volume":"73","author":"Lindner","year":"2013","journal-title":"Cancer Res"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3077","article-title":"Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely Upon Education From Tumor-Associated B Cells","volume":"75","author":"Bodogai","year":"2015","journal-title":"Cancer Res"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4316","article-title":"Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4 + T Cells to T-Regulatory Cells","volume":"71","author":"Olkhanud","year":"2011","journal-title":"Cancer Res"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discovery"},{"key":"B200","doi-asserted-by":"publisher","first-page":"e1075112","DOI":"10.1080\/2162402X.2015.1075112","article-title":"PD-L1 Mediated the Differentiation of Tumor-Infiltrating CD19 + B Lymphocytes and T Cells in Invasive Breast Cancer","volume":"5","author":"Guan","year":"2016","journal-title":"Oncoimmunology"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070131","article-title":"Interleukin-5 Supports the Expansion of Fas Ligand-Expressing Killer B Cells That Induce Antigen-Specific Apoptosis of CD4+ T Cells and Secrete Interleukin-10","volume":"8","author":"Klinker","year":"2013","journal-title":"PloS One"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3766","article-title":"Inhibitory Effects of B Cells on Antitumor Immunity","volume":"66","author":"Inoue","year":"2006","journal-title":"Cancer Res"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.09.026","article-title":"Regulatory B Cells Accelerate Hepatocellular Carcinoma Progression via CD40\/CD154 Signaling Pathway","volume":"355","author":"Shao","year":"2014","journal-title":"Cancer Lett"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for Myeloid-Derived Suppressor Cell Nomenclature and Characterization Standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0757","article-title":"High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response Through the Recruitment of Myeloid Suppressor Cells","volume":"64","author":"Serafini","year":"2004","journal-title":"Cancer Res"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2011.12.016","article-title":"IFN-\u03b3 Producing T Cells Contribute to the Increase of Myeloid Derived Suppressor Cells in Tumor-Bearing Mice After Cyclophosphamide Treatment","volume":"12","author":"Guo","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor Necrosis Factor-\u03b1 Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells During Chronic Inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4174","article-title":"Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells","volume":"67","author":"Sinha","year":"2007","journal-title":"Cancer Res"},{"key":"B209","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ccell.2018.02.007","article-title":"Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment","volume":"33","author":"Nakamura","year":"2018","journal-title":"Cancer Cell"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25726","article-title":"The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia","volume":"232","author":"Li","year":"2017","journal-title":"J Cell Physiol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"e1001162","DOI":"10.1371\/journal.pbio.1001162","article-title":"Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor","volume":"9","author":"Toh","year":"2011","journal-title":"PloS Biol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28622","article-title":"Subpopulations of Myeloid-Derived Suppressor Cells Impair T Cell Responses Through Independent Nitric Oxide-Related Pathways","volume":"134","author":"Raber","year":"2014","journal-title":"Int J Cancer"},{"key":"B213","doi-asserted-by":"publisher","first-page":"15424","DOI":"10.1038\/s41598-017-14970-0","article-title":"Nitric Oxide Mediated Inhibition of Antigen Presentation From DCs to CD4+ T Cells in Cancer and Measurement of STAT1 Nitration","volume":"7","author":"Markowitz","year":"2017","journal-title":"Sci Rep"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.2.989","article-title":"Antigen-Specific Inhibition of CD8 + T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species","volume":"172","author":"Kusmartsev","year":"2004","journal-title":"J Immunol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2012.755176","article-title":"Reactive Oxygen Species in the Immune System","volume":"32","author":"Yang","year":"2013","journal-title":"Int Rev Immunol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1580967","article-title":"Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment","volume":"2016","author":"Chen","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine Regulation by Myeloid Derived Suppressor Cells and Tolerance in Cancer: Mechanisms and Therapeutic Perspectives","volume":"222","author":"Rodr\u00edguez","year":"2008","journal-title":"Immunol Rev"},{"key":"B218","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","article-title":"Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine","volume":"70","author":"Srivastava","year":"2010","journal-title":"Cancer Res"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1038\/nri1434","article-title":"TCR \u03b6-Chain Downregulation: Curtailing an Excessive Inflammatory Immune Response","volume":"4","author":"Baniyash","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201449","article-title":"Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses Through IDO Expression and Correlate With Lymph Node Metastasis in Patients With Breast Cancer","volume":"190","author":"Yu","year":"2013","journal-title":"J Immunol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0569","article-title":"Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion","volume":"72","author":"Platten","year":"2012","journal-title":"Cancer Res"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1038\/nm1609","article-title":"Altered Recognition of Antigen is a Mechanism of CD8+ T Cell Tolerance in Cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat Med"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042028","article-title":"Boosting Antitumor Responses of T Lymphocytes Infiltrating Human Prostate Cancers","volume":"201","author":"Bronte","year":"2005","journal-title":"J Exp Med"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2939","article-title":"Molecular Pathways: Tumor-Infiltrating Myeloid Cells and Reactive Oxygen Species in Regulation of Tumor Microenvironment: Figure\u00a01","volume":"18","author":"Lu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B226","doi-asserted-by":"publisher","first-page":"e1320011","DOI":"10.1080\/2162402X.2017.1320011","article-title":"CD39\/CD73 Upregulation on Myeloid-Derived Suppressor Cells via TGF-\u03b2-mTOR-HIF-1 Signaling in Patients With non-Small Cell Lung Cancer","volume":"6","author":"Li","year":"2017","journal-title":"Oncoimmunology"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2460","article-title":"Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients With Ovarian Cancer","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Res"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1553-8","article-title":"Extracellular Adenosine Metabolism in Immune Cells in Melanoma","volume":"63","author":"Umansky","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"B229","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1593\/neo.131748","article-title":"Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma","volume":"15","author":"Iannone","year":"2013","journal-title":"Neoplasia"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2010.516450","article-title":"Up-Regulated Myeloid-Derived Suppressor Cell Contributes to Hepatocellular Carcinoma Development by Impairing Dendritic Cell Function","volume":"46","author":"Hu","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells Through Membrane-Bound TGF-\u03b21","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050463","article-title":"Tumor Cells Convert Immature Myeloid Dendritic Cells Into TGF-\u03b2\u2013Secreting Cells Inducing CD4+CD25+ Regulatory T Cell Proliferation","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J Exp Med"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10561","article-title":"TGF-\u03b2 Induces M2-Like Macrophage Polarization via SNAIL-Mediated Suppression of a Pro-Inflammatory Phenotype","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of Tumor-Associated Neutrophil Phenotype by TGF-\u03b2: \u201cN1\u201d Versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"B235","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41598-018-21061-1","article-title":"Epithelial-Mesenchymal Transition (EMT) Signature is Inversely Associated With T-Cell Infiltration in Non-Small Cell Lung Cancer (NSCLC)","volume":"8","author":"Chae","year":"2018","journal-title":"Sci Rep"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902725","article-title":"Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner","volume":"184","author":"Izhak","year":"2010","journal-title":"J Immunol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0348","article-title":"CCR5 + Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions","volume":"78","author":"Blattner","year":"2018","journal-title":"Cancer Res"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804253","article-title":"Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4 + and CD8 + T Cells","volume":"183","author":"Hanson","year":"2009","journal-title":"J Immunol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2015.10.015","article-title":"Myeloid Derived Suppressor Cells in Inflammatory Conditions of the Central Nervous System","volume":"1862","author":"Melero-Jerez","year":"2016","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2011.00495.x","article-title":"Myeloid-Derived Suppressor Cells Limit the Inflammation by Promoting T Lymphocyte Apoptosis in the Spinal Cord of a Murine Model of Multiple Sclerosis","volume":"21","author":"Molin\u00e9-Vel\u00e1zquez","year":"2011","journal-title":"Brain Pathol"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-287839","article-title":"Bone Marrow Myeloid-Derived Suppressor Cells (MDSCs) Inhibit Graft-Versus-Host Disease (GVHD) via an Arginase-1-Dependent Mechanism That is Up-Regulated by Interleukin-13","volume":"116","author":"Highfill","year":"2010","journal-title":"Blood"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v95.1.212","article-title":"Nitric Oxide-Producing CD11b+Ly-6g(Gr-1)+CD31(ER-MP12)+cells in the Spleen of Cyclophosphamide\u2013Treated Mice: Implications for T-Cell Responses in Immunosuppressed Mice","volume":"95","author":"Angulo","year":"2000","journal-title":"Blood"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.12.6720","article-title":"The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease","volume":"169","author":"St\u00fcve","year":"2002","journal-title":"J Immunol"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101816","article-title":"Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease","volume":"188","author":"Ioannou","year":"2012","journal-title":"J Immunol"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242092","article-title":"Myeloid - Derived Suppressor Cells in Type 1 Diabetes are an Expanded Population Exhibiting Diverse T-Cell Suppressor Mechanisms","volume":"15","author":"Grohov\u00e1","year":"2020","journal-title":"PloS One"},{"key":"B246","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/03009742.2012.716450","article-title":"Increased Circulating Myeloid-Derived Suppressor Cells Correlated Negatively With Th17 Cells in Patients With Rheumatoid Arthritis","volume":"42","author":"Jiao","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"B247","doi-asserted-by":"publisher","first-page":"331ra40","DOI":"10.1126\/scitranslmed.aae0482","article-title":"Arginase-1\u2013Dependent Promotion of T H 17 Differentiation and Disease Progression by MDSCs in Systemic Lupus Erythematosus","volume":"8","author":"Wu","year":"2016","journal-title":"Sci Transl Med"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903636","article-title":"Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models","volume":"185","author":"Yin","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1100\/2011\/213962","article-title":"Macrophage Polarization in Health and Disease","volume":"11","author":"Cassetta","year":"2011","journal-title":"Sci World J"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050647","article-title":"Monocyte Chemoattractant Protein-1 Expression and Macrophage Infiltration in Gliomas","volume":"93","author":"Leung","year":"1997","journal-title":"Acta Neuropathol"},{"key":"B251","article-title":"Significance of Macrophage Chemoattractant Protein-1 in Macrophage Recruitment, Angiogenesis, and Survival in Human Breast Cancer","volume":"6","author":"Ueno","year":"2000","journal-title":"Clin Cancer Res"},{"key":"B252","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s002620050603","article-title":"Macrophage Infiltration in Human non-Small-Cell Lung Cancer: The Role of CC Chemokines","volume":"49","author":"Arenberg","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00252.2012","article-title":"Inking Tumor-Associated Macrophages, Inflammation, and Intestinal Tumorigenesis: Role of MCP-1","volume":"303","author":"McClellan","year":"2012","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-016-0820-y","article-title":"Diverse Macrophages Polarization in Tumor Microenvironment","volume":"39","author":"Rhee","year":"2016","journal-title":"Arch Pharm Res"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141836","article-title":"CCL2-Induced Chemokine Cascade Promotes Breast Cancer Metastasis by Enhancing Retention of Metastasis-Associated Macrophages","volume":"212","author":"Kitamura","year":"2015","journal-title":"J Exp Med"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2010-0080OC","article-title":"Monocyte Chemoattractant Protein-1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8+ Cells","volume":"44","author":"Fridlender","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00078-4.Phase","article-title":"Phase 1b Study Targeting Tumour Associated Macrophages With CCR2 Inhibition Plus FOLFIRINOX in Locally Advanced and Borderline Resectable Pancreatic Cancer HHS Public Access","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0860-1","article-title":"High Systemic and Tumor-Associated IL-8 Correlates With Reduced Clinical Benefit of PD-L1 Blockade","volume":"26","author":"Yuen","year":"2020","journal-title":"Nat Med"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.02.026","article-title":"Interleukin-6 in Bone Metastasis and Cancer Progression","volume":"46","author":"Ara","year":"2010","journal-title":"Eur J Cancer"},{"key":"B260","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0139598","article-title":"Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis","volume":"10","author":"Zhao","year":"2015","journal-title":"PloS One"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2014.12.009","article-title":"Suppression of Antigen Presentation by IL-10","volume":"34","author":"Mittal","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1713543114","article-title":"Resident Macrophages of Pancreatic Islets Have a Seminal Role in the Initiation of Autoimmune Diabetes of NOD Mice","volume":"114","author":"Carrero","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B263","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.imlet.2014.03.006","article-title":"Macrophages: A Double-Edged Sword in Experimental Autoimmune Encephalomyelitis","volume":"160","author":"Jiang","year":"2014","journal-title":"Immunol Lett"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12910","article-title":"Implications of Macrophage Polarization in Autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0687","article-title":"Secretory Functions of Macrophages in the Human Pancreatic Islet Are Regulated by Endogenous Purinergic Signaling","volume":"69","author":"Weitz","year":"2020","journal-title":"Diabetes"},{"key":"B266","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0675-0","article-title":"Multiplex Quantitative Analysis of Cancer-Associated Fibroblasts and Immunotherapy Outcome in Metastatic Melanoma","volume":"7","author":"Wong","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1159\/000430251","article-title":"Macrophage Polarization Modulates Development of Systemic Lupus Erythematosus","volume":"37","author":"Li","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1635","article-title":"Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice","volume":"61","author":"Parsa","year":"2012","journal-title":"Diabetes"},{"key":"B269","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-019-0362-3","article-title":"TGF-\u03b2 in Fibrosis by Acting as a Conductor for Contractile Properties of Myofibroblasts","volume":"9","author":"Vall\u00e9e","year":"2019","journal-title":"Cell Biosci"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-12-0307","article-title":"Cancer-Associated Fibroblasts Drive the Progression of Metastasis Through Both Paracrine and Mechanical Pressure on Cancer Tissue","volume":"10","author":"Karagiannis","year":"2012","journal-title":"Mol Cancer Res"},{"key":"B271","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01611-0","article-title":"Regulation of Heterogeneous Cancer-Associated Fibroblasts: The Molecular Pathology of Activated Signaling Pathways","volume":"39","author":"Yoshida","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10204","article-title":"Epigenetic Switch Drives the Conversion of Fibroblasts Into Proinvasive Cancer-Associated Fibroblasts","volume":"6","author":"Albrengues","year":"2015","journal-title":"Nat Commun"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-021-00318-4","article-title":"Cancer-Associated Fibroblasts: Overview, Progress, Challenges, and Directions","volume":"28","author":"Ping","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00060","article-title":"Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment","volume":"7","author":"Liu","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112767","article-title":"TGF-\u03b2-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis","volume":"20","author":"Hao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B276","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41419-019-1873-x","article-title":"Transforming Growth Factor (TGF)-\u03b21-Induced miR-133a Inhibits Myofibroblast Differentiation and Pulmonary Fibrosis","volume":"10","author":"Wei","year":"2019","journal-title":"Cell Death Dis"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2544","article-title":"A Tense Situation: Forcing Tumour Progression","volume":"9","author":"Butcher","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1560","article-title":"Local Expression of Indoleamine 2,3 Dioxygenase in Syngeneic Fibroblasts Significantly Prolongs Survival of an Engineered Three-Dimensional Islet Allograft","volume":"59","author":"Jalili","year":"2010","journal-title":"Diabetes"},{"key":"B279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0146970","article-title":"Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes","volume":"11","author":"Jalili","year":"2016","journal-title":"PloS One"},{"key":"B280","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/imm.12584","article-title":"Tolerogenic Effect of Mouse Fibroblasts on Dendritic Cells","volume":"148","author":"Khosravi-Maharlooei","year":"2016","journal-title":"Immunology"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39104","article-title":"The Basics of Epithelial-Mesenchymal Transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2620","article-title":"Transitions Between Epithelial and Mesenchymal States: Acquisition of Malignant and Stem Cell Traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B283","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000337106","article-title":"Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells","volume":"79","author":"Ksiazkiewicz","year":"2012","journal-title":"Pathobiology"},{"key":"B284","doi-asserted-by":"crossref","DOI":"10.1201\/9780429258794","volume-title":"The Biology of Cancer","author":"Weinberg","year":"2013"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The Epithelial-Mesenchymal Transition Generates Cells With Properties of Stem Cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2015.07.012","article-title":"Epithelial\u2013Mesenchymal Plasticity: A Central Regulator of Cancer Progression","volume":"25","author":"Ye","year":"2015","journal-title":"Trends Cell Biol"},{"key":"B287","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1038\/ncomms6241","article-title":"Metastasis is Regulated via microRNA-200\/ZEB1 Axis Control of Tumour Cell PD-L1 Expression and Intratumoral Immunosuppression","volume":"5","author":"Chen","year":"2014","journal-title":"Nat Commun"},{"key":"B288","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-015-0421-2","article-title":"Bidirectional Crosstalk Between PD-L1 Expression and Epithelial to Mesenchymal Transition: Significance in Claudin-Low Breast Cancer Cells","volume":"14","author":"Alsuliman","year":"2015","journal-title":"Mol Cancer"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0977","article-title":"Hypoxia-Induced Epithelial-To-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis","volume":"76","author":"Ye","year":"2016","journal-title":"Cancer Res"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1891","article-title":"NK-Cell Editing Mediates Epithelial-To-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines","volume":"78","author":"Huergo-Zapico","year":"2018","journal-title":"Cancer Res"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.133","article-title":"TGF-\u03b21-Induced EMT Promotes Targeted Migration of Breast Cancer Cells Through the Lymphatic System by the Activation of CCR7\/CCL21-Mediated Chemotaxis","volume":"35","author":"Pang","year":"2016","journal-title":"Oncogene"},{"key":"B292","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-018-0818-9","article-title":"miR-190 Suppresses Breast Cancer Metastasis by Regulation of TGF-\u03b2-Induced Epithelial\u2013Mesenchymal Transition","volume":"17","author":"Yu","year":"2018","journal-title":"Mol Cancer"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgw011","article-title":"The Feedback Loop Between miR-124 and TGF-\u03b2 Pathway Plays a Significant Role in non-Small Cell Lung Cancer Metastasis","volume":"37","author":"Zu","year":"2016","journal-title":"Carcinogenesis"},{"key":"B294","doi-asserted-by":"publisher","first-page":"10597","DOI":"10.1038\/s41598-020-67325-7","article-title":"TGF-\u03b2 Induced EMT and Stemness Characteristics are Associated With Epigenetic Regulation in Lung Cancer","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.00031","article-title":"Parthenolide Inhibits Transforming Growth Factor \u03b21-Induced Epithelial-Mesenchymal Transition in Colorectal Cancer Cells","volume":"17","author":"Zhu","year":"2019","journal-title":"Intest Res"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153142","article-title":"RUNX1 Regulates TGF-\u03b2 Induced Migration and EMT in Colorectal Cancer","volume":"216","author":"Lu","year":"2020","journal-title":"Pathol Res Pract"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1434","article-title":"Epithelial\u2013Mesenchymal Transition Is Associated With a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma","volume":"22","author":"Lou","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2019.02.038","article-title":"IFN-\u03b3 Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer","volume":"240","author":"Imai","year":"2019","journal-title":"J Surg Res"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.607483","article-title":"The Epithelial-To-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders","volume":"8","author":"Di Gregorio","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B300","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11020310","article-title":"Organ Fibrosis and Autoimmunity: The Role of Inflammation in Tgf\u03b2-Dependent EMT","volume":"11","author":"Sisto","year":"2021","journal-title":"Biomolecules"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200215518","article-title":"Evidence That Fibroblasts Derive From Epithelium During Tissue Fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J Clin Invest"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.200900043","article-title":"Inflammation and EMT: An Alliance Towards Organ Fibrosis and Cancer Progression","volume":"1","author":"L\u00f3pez-Novoa","year":"2009","journal-title":"EMBO Mol Med"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101530","article-title":"The Interplay of Fibroblasts, the Extracellular Matrix, and Inflammation in Scar Formation","volume":"298","author":"Moretti","year":"2022","journal-title":"J Biol Chem"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of Fibrosis: Therapeutic Translation for Fibrotic Disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37581","article-title":"In Liver Fibrosis, Dendritic Cells Govern Hepatic Inflammation in Mice via TNF-\u03b1","volume":"119","author":"Connolly","year":"2009","journal-title":"J Clin Invest"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00301.2018","article-title":"Profibrotic Effect of IL-17A and Elevated IL-17RA in Idiopathic Pulmonary Fibrosis and Rheumatoid Arthritis-Associated Lung Disease Support a Direct Role for IL-17a\/IL-17RA in Human Fibrotic Interstitial Lung Disease","volume":"316","author":"Zhang","year":"2019","journal-title":"Am J Physiol Cell Mol Physiol"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.10.041","article-title":"The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA","volume":"9","author":"Mannion","year":"2014","journal-title":"Cell Rep"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2021.1877024","article-title":"The Effects of RNA Editing in Cancer Tissue at Different Stages in Carcinogenesis","volume":"18","author":"Kurkowiak","year":"2021","journal-title":"RNA Biol"},{"key":"B309","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/wrna.1665","article-title":"The Role of RNA Editing Enzyme ADAR1 in Human Disease","volume":"13","author":"Song","year":"2022","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"B310","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1038\/s41467-018-06405-9","article-title":"RNA Editing Derived Epitopes Function as Cancer Antigens to Elicit Immune Responses","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat Commun"},{"key":"B311","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225621","article-title":"APOBEC3-Mediated RNA Editing in Breast Cancer is Associated With Heightened Immune Activity and Improved Survival","volume":"20","author":"Asaoka","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B312","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.8.4621","article-title":"Human RNA-Specific Adenosine Deaminase ADAR1 Transcripts Possess Alternative Exon 1 Structures That Initiate From Different Promoters, One Constitutively Active and the Other Interferon Inducible","volume":"96","author":"George","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in Tumours Overcomes Resistance to Immune Checkpoint Blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"B314","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.02.021","article-title":"ADAR1: A New Target for Immuno-Oncology Therapy","volume":"73","author":"Bhate","year":"2019","journal-title":"Mol Cell"},{"key":"B315","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/S41591-018-0302-5","article-title":"Tumor-Derived IFN Triggers Chronic Pathway Agonism and Sensitivity to ADAR Loss","volume":"25","author":"Liu","year":"2019","journal-title":"Nat Med"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.1038\/nri3850","article-title":"Aicardi-Gouti\u00e8res Syndrome and the Type I Interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B317","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.12.034","article-title":"Dyschromatosis Symmetrica Hereditaria and Aicardi-Gouti\u00e8res Syndrome 6 Are Phenotypic Variants Caused by ADAR1 Mutations","volume":"136","author":"Kono","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B318","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/jmedgenet-2013-102038","article-title":"A Type I Interferon Signature Identifies Bilateral Striatal Necrosis Due to Mutations in ADAR1","volume":"51","author":"Livingston","year":"2014","journal-title":"J Med Genet"},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1389161","article-title":"Mutations in ADAR1, IFIH1, and RNASEH2B Presenting As Spastic Paraplegia","volume":"45","author":"Crow","year":"2014","journal-title":"Neuropediatrics"},{"key":"B320","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102329","article-title":"Increased Adenosine-to-Inosine RNA Editing in Rheumatoid Arthritis","volume":"106","author":"Vlachogiannis","year":"2020","journal-title":"J Autoimmun"},{"key":"B321","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.036","article-title":"Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus","volume":"23","author":"Roth","year":"2018","journal-title":"Cell Rep"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030683","article-title":"Adoptive Cell Therapy\u2014Harnessing Antigen-Specific T Cells to Target Solid Tumours","volume":"12","author":"Chru\u015bciel","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B323","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603237","article-title":"Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment","volume":"11","author":"Sadeqi Nezhad","year":"2020","journal-title":"Front Immunol"},{"key":"B324","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/brainsci10100758","article-title":"Anti-Cd20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab","volume":"10","author":"Florou","year":"2020","journal-title":"Brain Sci"},{"key":"B325","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02359","article-title":"Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Immunol"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000873","article-title":"Proinsulin-Specific T Regulatory Cells may Control Immune Responses in Type 1 Diabetes: Implications for Adoptive Therapy","volume":"8","author":"Gliwi\u0144ski","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104222","article-title":"Engineered Regulatory T Cells Expressing Myelin-Specific Chimeric Antigen Receptors Suppress EAE Progression","volume":"358","author":"De Paula Pohl","year":"2020","journal-title":"Cell Immunol"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.049","article-title":"Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor","volume":"136","author":"Elinav","year":"2009","journal-title":"Gastroenterology"},{"key":"B329","doi-asserted-by":"publisher","DOI":"10.2337\/db20-125-LB","article-title":"125-LB: Beta-Cell Antigen-Specific Chimeric Antigen Receptor Tregs for Type 1 Diabetes Prevention and Treatment","volume":"69","author":"Imam","year":"2020","journal-title":"Diabetes"},{"key":"B330","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117580","article-title":"Dendritic Cell Therapy in Cancer Treatment; the State-of-the-Art","volume":"254","author":"Sadeghzadeh","year":"2020","journal-title":"Life Sci"},{"key":"B331","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous Tolerogenic Dendritic Cells for Rheumatoid and Inflammatory Arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B332","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1595","article-title":"Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma","volume":"17","author":"Lipson","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B333","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1849","article-title":"Reversing T-Cell Dysfunction and Exhaustion in Cancer","volume":"22","author":"Zarour","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B334","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1269047","article-title":"Tumor PD-L1 Expression is Correlated With Increased TILs and Poor Prognosis in Penile Squamous Cell Carcinoma","volume":"6","author":"Deng","year":"2017","journal-title":"Oncoimmunology"},{"key":"B335","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.08.09","article-title":"The Association of PD-L1 Expression With the Efficacy of Anti-PD-1\/PD-L1 Immunotherapy and Survival of non-Small Cell Lung Cancer Patients: A Meta-Analysis of Randomized Controlled Trials","volume":"8","author":"Xu","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"B336","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.COT.0000479772.25205.6f","article-title":"FDA Approves Opdivo as Single Agent for Melanoma","volume":"38","year":"2016","journal-title":"Oncol Times"},{"key":"B337","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/S12248-021-00574-0","article-title":"Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics","volume":"23","author":"Twomey","year":"2021","journal-title":"AAPS J"},{"key":"B338","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240602","article-title":"Effect of CTLA-4 Chimeric Protein on Rat Autoimmune Anti-Glomerular Basement Membrane Glomerulonephritis","volume":"24","author":"Nishikawa","year":"1994","journal-title":"Eur J Immunol"},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu1029oa","article-title":"CTLA4Ig: A Novel Inhibitor of Costimulation","volume":"13","author":"Dall\u2019Era","year":"2004","journal-title":"Lupus"},{"key":"B340","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-Mediated Blockade of T-Cell Costimulation in Patients With Psoriasis Vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J Clin Invest"},{"key":"B341","doi-asserted-by":"publisher","DOI":"10.1002\/art.10294","article-title":"Costimulatory Blockade in Patients With Rheumatoid Arthritis: A Pilot, Dose-Finding, Double-Blind, Placebo-Controlled Clinical Trial Evaluating CTLA-4Ig and LEA29Y Eighty-Five Days After the First Infusion","volume":"46","author":"Moreland","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B342","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in Children With Juvenile Idiopathic Arthritis: A Randomised, Double-Blind, Placebo-Controlled Withdrawal Trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"B343","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000325915.00112.61","article-title":"CTLA4Ig Treatment in Patients With Multiple Sclerosis: An Open-Label, Phase 1 Clinical Trial","volume":"71","author":"Viglietta","year":"2008","journal-title":"Neurology"},{"key":"B344","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-Stimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: A Randomised, Double-Blind, Placebo-Controlled Trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"B345","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0047","article-title":"Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline","volume":"63","author":"Orban","year":"2014","journal-title":"Diabetes"},{"key":"B346","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040942","article-title":"CTLA-4\u2013Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells From Oxidative Stress in Nonobese Diabetic Mice","volume":"200","author":"Fallarino","year":"2004","journal-title":"J Exp Med"},{"key":"B347","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxn007","article-title":"CTLA-4 X Ig Converts Naive CD4+CD25- T Cells Into CD4+CD25+ Regulatory T Cells","volume":"20","author":"Razmara","year":"2008","journal-title":"Int Immunol"},{"key":"B348","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9527-5","article-title":"CTLA-4-Ig Therapy Diminishes the Frequency But Enhances the Function of Treg Cells in Patients With Rheumatoid Arthritis","volume":"31","author":"\u00c1lvarez-Quiroga","year":"2011","journal-title":"J Clin Immunol"},{"key":"B349","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801425","article-title":"Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance","volume":"202","author":"Glatigny","year":"2019","journal-title":"J Immunol"},{"key":"B350","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307311","article-title":"Protective Effects of Fc-Fused PD-L1 on Two Different Animal Models of Colitis","volume":"64","author":"Song","year":"2015","journal-title":"Gut"},{"key":"B351","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700407","article-title":"Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity","volume":"200","author":"Dixon","year":"2018","journal-title":"J Immunol"},{"key":"B352","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2020.06.001","article-title":"Inhibitory Receptor Agonists: The Future of Autoimmune Disease Therapeutics","volume":"67","author":"Grebinoski","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"B353","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.595950","article-title":"VISTA: A Target to Manage the Innate Cytokine Storm","volume":"11","author":"ElTanbouly","year":"2021","journal-title":"Front Immunol"},{"key":"B354","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic Cancer Vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B355","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.657768","article-title":"Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T Cell Therapy, and IL-2 Therapy","author":"Moorman","year":"2021","journal-title":"Front Immunol"},{"key":"B356","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1242\/DMM.015099","article-title":"Restoring the Balance: Immunotherapeutic Combinations for Autoimmune Disease","volume":"7","author":"Smilek","year":"2014","journal-title":"Dis Model Mech"},{"key":"B357","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2021.667075","article-title":"Defining Immunogenic and Radioimmunogenic Tumors","author":"Medler","year":"2021","journal-title":"Front Oncol"},{"key":"B358","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.016","article-title":"Immune-Related Adverse Events With Immune Checkpoint Blockade: A Comprehensive Review","volume":"54","author":"Michot","year":"2016","journal-title":"Eur J Cancer"},{"key":"B359","doi-asserted-by":"publisher","DOI":"10.1177\/2054270417746905","article-title":"Unleashing the Tiger \u2013 Iatrogenic Autoimmunity From Cancer Immunotherapy Drugs","volume":"9","author":"Luu","year":"2018","journal-title":"JRSM Open"},{"key":"B360","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"B361","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.102","article-title":"Malignancy After Renal Transplantation: The Role of Immunosuppression","volume":"6","author":"Rama","year":"2010","journal-title":"Nat Rev Nephrol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.793234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T03:53:19Z","timestamp":1675569199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.793234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":361,"alternative-id":["10.3389\/fimmu.2022.793234"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.793234","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"article-number":"793234"}}